carboplatin

Neither toxicity nor dose intensity of carboplatin is affected by glomerular filtration rate versus body surface area dose calculation in gynecologic malignancy
K. S. Tonkin, L. Levin, J. Powe

International Journal of Gynecologic Cancer Aug 1994, 4 (5) 315-319; DOI: 10.1046/j.1525-1438.1994.04050315.x
Carboplatin and etoposide as first-line chemotherapy in advanced epithelial ovarian cancer
D. Z. Edelmann, T. Peretz, V. Barak, S. O. Anteby

International Journal of Gynecologic Cancer Oct 1995, 5 (6) 443-448; DOI: 10.1046/j.1525-1438.1995.05060443.x
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
Philipp Harter, Jalid Sehouli, Alexander Reuss, Klaus Baumann, Lars Hanker, Rainer Kimmig, Willibald Schröder, Alexander Burges, Martina Gropp-Meier, Christian Kurzeder, Sven Mahner, Ulrich Canzler, Hans-Joachim Lück, Werner Meier, Tanja Fehm, Andreas du Bois

International Journal of Gynecologic Cancer Nov 2016, 26 (9) 1636-1641; DOI: 10.1097/IGC.0000000000000831
Carboplatin and Nonpegylated Liposomal Doxorubicin in Primary Advanced or Recurrent Endometrial Cancer: A Phase 2 Trial Conducted by AGO Austria
Birgit Volgger, Alain G. Zeimet, Alexander Reinthaller, Edgar Petru, Christian Schauer, Michaela Klein, Ursula Sevelda-Schwarzgruber, Gerhard Bogner, Gerhard Wolfram, Christian Marth

International Journal of Gynecologic Cancer Feb 2015, 25 (2) 257-262; DOI: 10.1097/IGC.0000000000000352
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer
Katherine LaVigne, David M. Hyman, Qin C. Zhou, Alexia Iasonos, William P. Tew, Carol Aghajanian, Vicky Makker, Martee L. Hensley, Jason Konner, Rachel N. Grisham, Nicholas Cangemi, Krysten Soldan, David R. Spriggs, Paul J. Sabbatini, Roisin E. O'Cearbhaill

International Journal of Gynecologic Cancer Jun 2018, 28 (6) 1176-1182; DOI: 10.1097/IGC.0000000000001280
Paclitaxel, Carboplatin, and Bevacizumab in Advanced and Recurrent Endometrial Carcinoma
Peter G. Rose, Shamshad Ali, Mehdi Moslemi-Kebria, Fiona Simpkins

International Journal of Gynecologic Cancer Mar 2017, 27 (3) 452-458; DOI: 10.1097/IGC.0000000000000891
The Efficacy of Low-Dose Paclitaxel Added to Combination Chemotherapy of Carboplatin and Gemcitabine or Pegylated Liposomal Doxorubicin
Shoji Nagao, Norihiro Iwasa, Akira Kurosaki, Tadaaki Nishikawa, Tatsuya Hanaoka, Kosei Hasegawa, Keiichi Fujiwara

International Journal of Gynecologic Cancer Mar 2016, 26 (3) 443-448; DOI: 10.1097/IGC.0000000000000630
Adjuvant Carboplatin, Paclitaxel, and Vaginal Cuff Brachytherapy for Stage III Endometrial Cancer: Analysis of Outcomes and Patterns of Recurrence Based on Pathologic Characteristics
Melissa Rasar Young, Susan A. Higgins, Elena Ratner, James B. Yu, Sheida Mani, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Peter E. Schwartz, Shari Damast

International Journal of Gynecologic Cancer Mar 2015, 25 (3) 431-439; DOI: 10.1097/IGC.0000000000000376
Desensitization With Oxaliplatin in Patients Intolerant of Carboplatin Desensitization
Peter G. Rose, Carol Metz, Nicolas Link

International Journal of Gynecologic Cancer Nov 2014, 24 (9) 1603-1606; DOI: 10.1097/IGC.0000000000000295
Concomitant Paclitaxel Plus Carboplatin and Radiotherapy for High-Risk or Advanced Endometrial Cancer
Qiang Wen, ZhuYan Shao, ZhengYan Yang

International Journal of Gynecologic Cancer May 2013, 23 (4) 685-689; DOI: 10.1097/IGC.0b013e3182808232

Main menu

carboplatin

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

carboplatin

Pages